Skip to main content
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.
Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation.
Use of atorvastatin in systemic lupus erythematosus in children and adolescents.
Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood.
Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment.
Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort.
Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus.
Epstein-Barr virus-associated B cell lymphoproliferative disease in a child with neonatal-onset multisystem inflammatory disease.
Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus.
Thrombosis and pediatric Wegener's granulomatosis: acquired and genetic risk factors for hypercoagulability.